Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters
December 17, 2021
Tickers
GILD
MRK
Tags
Market News
GILD
European Medicines Agency
From
Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
Tags
Benzinga
Biotech
lymphoma
From
Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
December 13, 2021
Tickers
GILD
Tags
News
Health Care
ASH21
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Tickers
ABBV
ALL
ALSN
AMGN
Tags
PATH
FUBO
WRB
From
Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
Tickers
GILD
RCUS
Tags
GILD
Market News
Recent Press Releases
From
Motley Fool
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
Tickers
GILD
MRK
NRXP
PFE
Tags
PFE
Recent Press Releases
MRK
From
Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Tickers
ACAD
APTX
AZN
BLU
Tags
ACAD
APTX
IBB
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Tickers
AAL
AAPL
ACEL
AMGN
Tags
Market News
NVS
SIVB
From
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
IMGN
Market News
NVS
From
Benzinga
Gilead Recalls Two Lots Of Remdesivir Due To Presence Of Glass Particulates
December 06, 2021
Tickers
GILD
Tags
Market News
GILD
FDA
From
Benzinga
December SPAC Merger Calendar: Upcoming Votes, Stocks To Watch
December 05, 2021
Tickers
AAL
ADF
ATHN
AXP
Tags
IPOs
MT
artificial intelligence
From
Benzinga
Got $1,000? Check Out These 3 Top Biotech Stocks
December 03, 2021
Tickers
BEAM
GILD
VRTX
Tags
BEAM
Market News
Recent Press Releases
From
Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
Tickers
ABBV
BNTX
GILD
LLY
Tags
PFE
ABBV
LLY
From
Motley Fool
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
November 30, 2021
Tickers
GILD
GSK
LLY
MRK
Tags
MRK
VIR
GILD
From
MarketWatch
Why NRx Pharmaceuticals Stock Soared Today
November 29, 2021
Tickers
GILD
NRXP
Tags
NRXP
Recent Press Releases
Market News
From
Motley Fool
Why Are NRx Pharma's Shares Soaring Premarket?
November 29, 2021
Tickers
GILD
NRXP
Tags
why it's moving
NRXP
Market News
From
Benzinga
3 Dividend Stocks That Are Dirt Cheap Right Now
November 25, 2021
Tickers
GILD
MSBI
WU
Tags
GILD
WU
Recent Press Releases
From
Motley Fool
A Look Into Gilead Sciences Debt
November 24, 2021
Tickers
GILD
Tags
News
BZI/Debt
Benzinga
From
Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
Tickers
GILD
MRK
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Gilead's Trodelvy Approved In Europe For Aggressive Form Of Breast Cancer
November 23, 2021
Tickers
GILD
Tags
Benzinga
Health Care
Biotech
From
Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
Tickers
AADI
ABEO
AMYT
APLT
Tags
SYBX
ABEO
GILD
From
Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
Tickers
AMGN
AZN
BIIB
BMY
Tags
PFE
SNY
NVO
From
Motley Fool
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
Tickers
BLUE
CRSP
GILD
VRTX
Tags
Market News
BLUE
GILD
From
Motley Fool
Is Merck Stock a Buy?
November 20, 2021
Tickers
GILD
MRK
REGN
XLRN
Tags
MRK
GILD
Market News
From
Motley Fool
Gilead Files US Application For Bulevirtide In Severe Form Of Viral Hepatitis
November 19, 2021
Tickers
GILD
Tags
GILD
Market News
General
From
Benzinga
Why Are Arcus Biosciences Shares Trading Higher Today?
November 18, 2021
Tickers
GILD
RCUS
Tags
Movers
Biotech
Benzinga
From
Benzinga
Why Arcus Biosciences Stock Is On Fire Today
November 18, 2021
Tickers
GILD
RCUS
Tags
RCUS
GILD
Market News
From
Motley Fool
2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash
November 15, 2021
Tickers
ABBV
GILD
Tags
GILD
ABBV
Recent Press Releases
From
Motley Fool
On Target: This Company Says It Delivers Drugs Exactly How You Need Them
November 15, 2021
Tickers
GILD
MTNB
Tags
GILD
Partner Content
Market News
From
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Tickers
APTO
APYX
BIIB
BLFS
Tags
FDA
PROG
IBB
From
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.